Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 136445 |
| Drug Identification Number | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-09-22 |
| Actual start date | 2021-09-22 |
| Estimated end date | 2021-12-31 |
| Actual end date | 2021-10-01 |
| Shortage status | Resolved |
| Updated date | 2022-01-31 |
| Company comments | Allocations will be increased to cover 100% of the 100ml demand plus 50% of the 200ml demand on a 2:1 conversion ratio. For example, 2 vials of 100ml = 1 vial of 200ml. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-03-26 | English | Compare |